CLINICAL TRIALS STARGARDT

Actualmente estos son los últimos ensayos clínicos de Stargardt.
Si quieres participar en alguno de ellos ponte en contacto con la persona que dirige el mismo.

NO SON TRATAMIENTOS; son ensayos clínicos.

¿Qué es un ensayo clínico?

Un ensayo clínico es una evaluación experimental de un producto, sustancia, medicamentotécnica diagnóstica o terapéutica que, en su aplicación a seres humanos, pretende valorar su eficacia y seguridad.

Los estudios de prometedores tratamientos nuevos o experimentales en pacientes se conocen como ensayos clínicos. Un ensayo clínico se realiza sólo cuando hay razones para creer que el tratamiento que se está estudiando puede ser beneficioso para el paciente. Los tratamientos usados en los ensayos clínicos con frecuencia demuestran tener beneficios reales. Los investigadores realizan estudios sobre nuevos tratamientos para conocer la utilidad del nuevo tratamiento, el mecanismo de acción del nuevo tratamiento, si la efectividad es mayor que otros tratamientos ya disponibles, los efectos secundarios del nuevo tratamiento y si son mayores o menores que el tratamiento convencional, si supera los beneficios a los efectos secundarios y en qué pacientes el nuevo tratamiento es más útil.

UN ENSAYO CLÍNICO PUEDE DURAR HASTA QUE SE REALICE UN MEDICAMENTO UNA MEDIA DE DIEZ AÑOS.

Rank Status Study
1 Completed Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-Like Macular Dystrophy

Condition: Macular Degeneration
Intervention: Drug: Docosahexaenoic Acid (DHA) Dietary Supplement
2 Recruiting A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

Condition: Stargardt Disease
Intervention:
3 Recruiting Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease

Condition: Stargardt Disease
Intervention:
4 Recruiting Phase I/IIa Study of StarGen in Patients With Stargardt Macular Degeneration

Condition: Stargardt Disease
Intervention: Genetic: StarGen
5 Enrolling by invitation A Study to Determine the Long Term Safety, Tolerability and Biological Activity of StarGen™ in Patients With Stargardt’s Macular Degeneration

Condition: Stargardt Disease
Intervention: Drug: StarGen
6 Recruiting Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt’s Macular Dystrophy

Condition: Stargardt’s Macular Dystrophy
Intervention: Biological: MA09-hRPE Cellular therapy
7 Completed Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Condition: Macular Dystrophy, Corneal
Interventions: Drug: 4-Methylpyrazole;   Other: saline
8 Recruiting Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt’s Macular Dystrophy(SMD)

Condition: Stargardt’s Macular Dystrophy
Intervention: Biological: MA09-hRPE
9 Recruiting Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt’s Macular Dystrophy (SMD)

Conditions: Stargardt’s Macular Dystrophy;   Fundus Flavimaculatus;   Juvenile Macular Dystrophy
Intervention: Biological: Biological: MA09-hRPE Cellular therapy
10 Recruiting Saffron Supplementation in Stargardt’s Disease

Conditions: Retinal Degeneration;   Genetic Disease;   Single-Gene Defects;   Macular Dystrophy
Interventions: Dietary Supplement: Saffron supplementation;   Other: placebo
11 Unknown  DHA Supplementation in Patients With STGD3

Condition: Dominantly Inherited Stargardt’s Disease (STGD3)
Intervention: Dietary Supplement: Over the counter DHA/EPA dietary supplementation
12 Completed Microcurrent Stimulation to Treat Macular Degeneration

Conditions: Retinal Diseases;   Stargardt’s Disease;   Retinitis Pigmentosa
Intervention:
13 Recruiting High Resolution Retinal Imaging

Conditions: Stargardts;   Retinitis Pigmentosa;   Age-related Macular Degeneration;   Choroideremia;   Geographic Atrophy
Intervention: Procedure: Retinal imaging
14 Recruiting Stem Cell Ophthalmology Treatment Study

Conditions: Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   Glaucoma
Interventions: Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)
15 Recruiting Natural History of Eye Diseases Related to ABCA4 Mutations

Conditions: Retinal Degeneration;   ABCA4-Related Retinopathies
Intervention:

 

 

Rank Status Study
1 Completed Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Condition: Macular Dystrophy, Corneal
Interventions: Drug: 4-Methylpyrazole;   Other: saline
2 Completed Microcurrent Stimulation to Treat Macular Degeneration

Conditions: Retinal Diseases;   Stargardt’s Disease;   Retinitis Pigmentosa
Intervention:

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s